Paper33882157
Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir.
Ueda M and 4 others. Clin Pharmacol Ther, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir. Papers, record 33882157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33882157
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amides | Major topic |
| Antiviral Agents | Major topic |
| Drug Approval | Major topic |
| Pyrazines | Major topic |
| Adenosine Monophosphate | |
| Alanine | |
| COVID-19 | |
| Clinical Trials, Phase III as Topic | |
| Dexamethasone | |
| Double-Blind Method | |
| Humans | |
| Japan | |
| COVID-19 Drug Treatment |
Source PubMed
References3
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32445440 | Remdesivir for the Treatment of Covid-19 - Final Report. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32445440 | PubMed |
| 2 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 3 | 32870235 | Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval. | JAMA | 2020 | https://conductscience.org/library/papers/32870235 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42844389 | Towards broader-spectrum direct-acting antivirals against RNA viruses. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/42844389 | PubMed |
| 40103591 | Dysregulated glycerophospholipid metabolism in amygdala may mediate favipiravir-induced anxiety-like behaviors in mice. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40103591 | PubMed |
| 38402214 | Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID). | Pneumonia (Nathan) | 2024 | https://conductscience.org/library/papers/38402214 | PubMed |
| 37168925 | Impact of common comorbidities on antimicrobial consumption and mortality amongst critically ill COVID-19 patients: A retrospective two center study in Saudi Arabia. | Clin Infect Pract | 2023 | https://conductscience.org/library/papers/37168925 | PubMed |
| 37142688 | Therapeutics for COVID-19. | Nat Microbiol | 2023 | https://conductscience.org/library/papers/37142688 | PubMed |
| 36366550 | Antiviral Potential of Natural Resources against Influenza Virus Infections. | Viruses | 2022 | https://conductscience.org/library/papers/36366550 | PubMed |
| 35308532 | Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/35308532 | PubMed |
| 34391321 | An update of anti-viral treatment of COVID-19 | Turk J Med Sci | 2021 | https://conductscience.org/library/papers/34391321 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33882157
GET https://conductscience.org/api/papers/v1/33882157/authors